Loading…
← CockpitCompetitor Analysis › 002919.SZ Mingchen Health Co., Ltd. Class AOpen in the cockpit ↗

Mingchen Health Co., Ltd. Class A002919.SZCompetitor analysis, valuation and peers

China · CNY·Information Technology›Packaged Software
Momentum neutral 44
Mkt cap
$640M
US dollars, full cap
Free float
54%
of shares outstanding
$/day
$16.2M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-20.7 pp
WACC 7.9%
Hurdle
+10 pp
Req g minus delivered
Next earnings
174 days
29 Apr 2027
Close · CNYCN¥16.04
1D-3.1%
1W+7.9%
1M-2.8%
3M-5.3%
6M-33.1%
YTD-30.2%
1Y-10.1%
ATR %6.0%
52w lowhigh42.5% off high

What Mingchen Health does

Employees: 1,305

Mingchen Health at a glance

Size Mingchen Health (002919.SZ) is a China Information Technology company (Packaged Software) with a market value of $640M, the 3264th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥16.04 on 6 Nov 2026.

Performance Over six months the shares fell 33.1%, against -11.2% for the median peer and -16.4% for the China market (cap-weighted) — 3rd lowest of 21 in its peer set.

Growth Revenue grew 19.0% over the last twelve months (peer median +2.6%); the operating margin is -5.4% (peer median 5.5%).

Valuation It trades at 2.4× enterprise value to sales against a peer median of 4.0× (5th cheapest of 19).

Price implies For today's price to make sense, revenue must grow about 27% a year for seven years (Req g). Recent delivered growth is +17%, so the hurdle is +10 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 20.7 points below its cost of capital (7.9% WACC).

Next results Next results expected around 29 Apr 2027 (exchange calendar; dates can move).

Relative performance

608010011 May 202611 Aug 20266 Nov 2026Peer median 89002919.SZ 66
Six months, rebased to 100: Mingchen Health against the median of its 20 peers (local-currency closes).

Mingchen Health financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥1.70BCN¥1.51BCN¥1.38BCN¥1.63BCN¥942M
Revenue growth—+10%-16%+74%—
Gross profitCN¥933MCN¥797MCN¥702MCN¥956MCN¥471M
EBITDA-CN¥44.0MCN¥16.2MCN¥101MCN¥264MCN¥37.8M
Net income-CN¥17.8MCN¥28.3MCN¥46.7MCN¥70.4MCN¥25.4M
Free cash flowCN¥65.5MCN¥2.38MCN¥117MCN¥56.7M-CN¥76.5M
Capital expenditureCN¥60.9MCN¥86.5MCN¥48.6MCN¥12.7MCN¥151M
Total debtCN¥77.3MCN¥111MCN¥23.0MCN¥53.1MCN¥87.8M

Quarterly statements and history in the cockpit →

Mingchen Health competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%-20%0%+20%688023301213HYQPRTHALFA300380300299301556300271RAY-B688207278A003007HQRCATNEWGEN3693600756002919.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Mingchen Health is the large dot.

Fundamentals: revenue growth against valuation

0%+200%+400%+600%0×10×20×688023301213HYQALFA300299301556RAY-B688207278A003007RCAT3693002919.SZRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Mingchen Health is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%688023HYQPRTHALFA300299301556NEWGEN3693002919.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Mingchen Health is the large dot.

Mingchen Health competitors and peer comparison

How Mingchen Health compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Mingchen Health against its 20 peers (data as of 6 Nov 2026)
Measure002919.SZPeer medianRank in peer set
1-month return-2.8%-3.7%10th highest of 21
6-month return-33.1%-11.2%3rd lowest of 21
Distance from 52-week high-42.5%-38.1%9th lowest of 21
Revenue growth (TTM)+19.0%+2.6%4th highest of 20
Operating margin-5.4%5.5%6th lowest of 20
EV / Sales2.4×4.0×5th cheapest of 19
Growth the price implies (Req g, 7 yrs)27.2%21.7%3rd most demanding of 10
Growth delivered (Del g)+17.5%+14.0%4th highest of 10
Hurdle (Req g minus delivered)+9.7 pp+2.6 pp4th most demanding of 10
ROIC minus cost of capital-20.7 pp-4.8 pp4th lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Mingchen Health 002919.SZChina$640M-33%+19%-5%2.4×27.2%+17.5%
DBAPPSecurity 688023.SSChina$646M-6%+2%-5%1.8×5.6%+10.3%
Sichuan Discovery Dream Science & Technology 301213.SZChina$633M-26%+34%2%19.9×n/an/a
Hypoport HYQ.DEGermany$648M-2%-5%6%1.1×22.2%+9.2%
Priority Technology PRTHUnited States$650M+18%+9%14%1.6×2.9%+18.7%
Alfa Financial Software ALFA.LUnited Kingdom$651M+4%+8%30%3.6×-2.0%+9.9%
Shanghai Amarsoft Information & Technology 300380.SZChina$628M-30%-2%4%3.8×n/an/a
Hello Group Inc. Sponsored ADR MOMOUnited States$654M-26%0%11%n/an/an/a
Fuchun Technology 300299.SZChina$623M-2%+3%2%10.8×54.9%-4.8%
Zhejiang TOP Cloud-agri Technology 301556.SZChina$620M-34%-14%13%7.7×30.7%+14.0%
Beijing Thunisoft 300271.SZChina$663M-13%+11%-9%1.8×n/an/a
RaySearch Laboratories RAY-B.STSweden$618M+1%+3%19%4.7×7.3%+15.6%
Beijing Deep Glint Technology 688207.SSChina$663M+15%-14%-195%27.3×n/an/a
Terra Drone 278A.TJapan$618M+564%+14%-26%17.8×n/an/a
Beijing ZZNode Technologies 003007.SZChina$617M-23%+64%20%6.8×n/an/a
Horizon Quantum HQUnited States$617M+14%n/an/an/an/an/a
Red Cat RCATUnited States$617M-61%+693%-150%4.3×n/an/a
Newgen Software Technologies NEWGEN.NSIndia$665M-12%+6%24%3.1×21.7%+18.5%
Pansoft 300996.SZChina$665M-11%-4%11%5.1×n/an/a
AIC 3693.TWOTaiwan$667M-22%-21%8%2.9×22.9%+20.2%
Inspur Software 600756.SSChina$669M-23%-25%-25%3.4×n/an/a

Questions

Which companies are Mingchen Health's closest peers?
The cockpit's peer set: DBAPPSecurity (688023.SS), Sichuan Discovery Dream Science & Technology (301213.SZ), Hypoport (HYQ.DE), Priority Technology (PRTH), Alfa Financial Software (ALFA.L), Shanghai Amarsoft Information & Technology (300380.SZ), Hello Group Inc. Sponsored ADR (MOMO), Fuchun Technology (300299.SZ).
Is Mingchen Health expensive compared with its peers?
On ev / sales it trades at 2.4× against a peer median of 4.0×, 5th cheapest of 19 in its peer set. For today's price to make sense, revenue must grow about 27% a year for seven years (Req g). Recent delivered growth is +17%, so the hurdle is +10 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Mingchen Health stock performed?
Over six months to 6 Nov 2026 the shares returned -33.1% against -11.2% for the median peer; over one year -10.1%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.